Search for Clinical Trial Results
Nose Neoplasms - 25 Studies Found
Status | Study |
Terminated |
Study Name: Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer Condition:
|
Active, not recruiting |
Study Name: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. Condition:
|
Completed |
Study Name: TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck Condition:
|
Withdrawn |
Study Name: Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy Condition:
|
Active, not recruiting |
Study Name: Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer Condition:
|